COMMUNIQUÉS West-GlobeNewswire

DEINOVE invited to present at the 29th congress of the European Society of Clinical Microbiology and Infectious Diseases
12/04/2019
Georges GAUDRIAULT, Scientific Director of DEINOVE, will give a talk at the ECCMID, at the ‘Therapeutics pipeline corner’, on this coming Sunday, April 14 th , in Amsterdam. He will describe the progress of the DNV3837 [...]
Basilea reports isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
12/04/2019
Basel, Switzerland, April 12, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that a broad range of posters and presentations on the antifungal isavuconazole (Cresemba ® ) and the antibiotic ceftobiprole ( [...]
PhaseBio Announces Pricing of Public Offering of Common Stock
12/04/2019
MALVERN, Pa., and SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Cooper Fitness Center Introduces Move.Laugh.Connect. Program
11/04/2019
Cooper Program For Total Well-being Extends Functional Years DALLAS, April 11, 2019 (GLOBE NEWSWIRE) -- Cooper Fitness Center announces a new program, Move.Laugh.Connect. (MLC) as a balanced program for total well-being [...]
Cerner and naviHealth Expand Relationship, Plan to Launch Offering for Bundled Payments for Care Improvement Advanced (BPCI Advanced)
11/04/2019
KANSAS CITY, Mo., April 11, 2019 (GLOBE NEWSWIRE) -- Health care providers that want to participate in Medicare’s Bundled Payments for Care Improvement Advanced program (BPCI Advanced) can soon look to Cerner , a global [...]
Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business
11/04/2019
LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of common stock [...]
KemPharm Completes KP415 Pre-NDA Meeting with FDA
11/04/2019
KP415 NDA Filing Anticipated in Late Q2 or Early Q3 2019 Conference Call Scheduled for Today, Thursday, April 11, 2019 at 5:00 p.m. ET CELEBRATION, Fla., April 11, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH [...]
UPDATE – Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th
11/04/2019
PLEASANTON, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will release its 2019 first quarter [...]
VBI Vaccines Appoints Joanne Cordeiro to Board of Directors
11/04/2019
CAMBRIDGE, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
11/04/2019
New Meta-Analysis Data Suggests IV Meloxicam Produces Largest SPID, Greater Reduction in Opioid Use and Better Safety Profile Compared to Other Non-Opioid Medications for Moderate to Severe Pain Abstract Among the [...]
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Appointment of Darren Cline as U.S. Chief Commercial Officer
11/04/2019
CARLSBAD, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, [...]
COPE Health Solutions Adds Population Health and Value-Based Payments Experts
11/04/2019
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- COPE Health Solutions has expanded its senior leadership team with the addition of Robert A. Minkin, FACHE, as Principal and Samuel Shutman as Senior Vice President. As [...]
LONG ISLAND PLASTIC SURGICAL GROUP RAISES $30,000 FOR RESURGE INTERNATIONAL
11/04/2019
The Funds Will Go Towards Continuing Dr. Vincent DiGregorio's Legacy of Providing Free Medical Training to Communities in Need Garden City, NY, April 11, 2019 (GLOBE NEWSWIRE) -- Long Island Plastic Surgical Group ( [...]
Aleafia Health Opens the Market
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) opened the market at the Toronto Stock Exchange (“TSX”) in recognition of the [...]
Tecan strengthens development and operations organizations
11/04/2019
Dr. Wael Yared appointed as CTO and Head Research & Development and a member of the Management Board Ulrich Kanter will continue to lead the Operations division with increased responsibilities and scope Männedorf, [...]
OSE Immunotherapeutics Announces Publication on Anti-IL-7 Receptor Antagonist, OSE-127, in The Journal of Clinical Investigation
11/04/2019
Data further support OSE-127’s potential in chronic inflammatory bowel diseases Confirm novel and differentiated mechanism of action of OSE-127, currently being investigated in an ongoing Phase 1 trial NANTES, France, [...]
Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.
11/04/2019
MONTREAL, April 11, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that the Québec Superior Court issued earlier today a final order [...]
Clementia Pharmaceutiques Inc. fait approuver par la cour son plan d’arrangement avec Ipsen S.A.
11/04/2019
MONTRÉAL, 11 avr. 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceutiques Inc. (Nasdaq : CMTA) (« Clementia » ou la « Société ») est heureuse d’annoncer que la Cour supérieure du Québec a rendu plus tôt aujourd’hui une [...]
Virbac : 2019 first quarter revenue rose by +10.9% at comparable exchange rates
11/04/2019
KEY FIGURES Revenue 1 st quarter 2019 €217.5 million Total growth +12.4% Growth at constant exchange rates +10.9% Growth at constant exchange rates and scope 1 +10.9% of which companion animals +17.6% (+9.3% outside of [...]

Pages